FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034895714> ?p ?o ?g. }

• W2034895714 endingPage "1074" @default.
• W2034895714 startingPage "1067" @default.
• W2034895714 abstract "Secretory vesicles of neuroendocrine cells possess multiple proteases for proteolytic processing of proteins into biologically active peptide components, such as peptide hormones and neurotransmitters. The importance of proteases within secretory vesicles predicts the presence of endogenous protease inhibitors in this subcellular compartment. Notably, serpins represent a diverse class of endogenous protease inhibitors that possess selective target protease specificities, defined by the reactive site loop domains (RSL). In the search for endogenous serpins in model secretory vesicles of neuroendocrine chromaffin cells, the presence of serpins related to alpha1-antichymotrypsin (ACT) was detected by Western blots with anti-ACT. Molecular cloning revealed the primary structures of two unique serpins, endopin 1 and endopin 2, that possess homology to ACT. Of particular interest was the observation that distinct RSL domains of these new serpins predicted that endopin 1 would inhibit trypsin-like serine proteases cleaving at basic residues, and endopin 2 would inhibit both elastase and papain that represent serine and cysteine proteases, respectively. Endopin 1 showed selective inhibition of trypsin, but did not inhibit chymotrypsin, elastase, or subtilisin. Endopin 2 demonstrated cross-class inhibition of the cysteine protease papain and the serine protease elastase. Endopin 2 did not inhibit chymotrypsin, trypsin, plasmin, thrombin, furin, or cathepsin B. Endopin 1 and endopin 2 each formed SDS-stable complexes with target proteases, a characteristic property of serpins. In neuroendocrine chromaffin cells from adrenal medulla, endopin 1 and endopin 2 were both localized to secretory vesicles. Moreover, the inhibitory activity of endopin 2 was optimized under reducing conditions, which required reduced Cys-374; this property is consistent with the presence of endogenous reducing agents in secretory vesicles in vivo. These new findings demonstrate the presence of unique secretory vesicle serpins, endopin 1 and endopin 2, which possess distinct target protease selectivities. Endopin 1 inhibits trypsin-like proteases; endopin 2 possesses cross-class inhibition for inhibition of papain-like cysteine proteases and elastase-like serine proteases. It will be of interest in future studies to define the endogenous protease targets of these two novel secretory vesicle serpins." @default.
• W2034895714 created "2016-06-24" @default.
• W2034895714 creator A5075467879 @default.
• W2034895714 creator A5082200157 @default.
• W2034895714 date "2002-08-27" @default.
• W2034895714 modified "2023-09-23" @default.
• W2034895714 title "Novel Secretory Vesicle Serpins, Endopin 1 and Endopin 2: Endogenous Protease Inhibitors with Distinct Target Protease Specificities" @default.
• W2034895714 cites W1215858103 @default.
• W2034895714 cites W1495275626 @default.
• W2034895714 cites W1497805203 @default.
• W2034895714 cites W1558566725 @default.
• W2034895714 cites W1559409164 @default.
• W2034895714 cites W1559642460 @default.
• W2034895714 cites W1836307744 @default.
• W2034895714 cites W1971077935 @default.
• W2034895714 cites W1984319724 @default.
• W2034895714 cites W1997226028 @default.
• W2034895714 cites W2001341873 @default.
• W2034895714 cites W2006876120 @default.
• W2034895714 cites W2017708875 @default.
• W2034895714 cites W2033339853 @default.
• W2034895714 cites W2039518218 @default.
• W2034895714 cites W2040887234 @default.
• W2034895714 cites W2044991634 @default.
• W2034895714 cites W2047755267 @default.
• W2034895714 cites W2051582871 @default.
• W2034895714 cites W2058124777 @default.
• W2034895714 cites W2059117640 @default.
• W2034895714 cites W2059408123 @default.
• W2034895714 cites W2063072860 @default.
• W2034895714 cites W2069263559 @default.
• W2034895714 cites W2069464512 @default.
• W2034895714 cites W2071781217 @default.
• W2034895714 cites W2082012658 @default.
• W2034895714 cites W2086056405 @default.
• W2034895714 cites W2086517187 @default.
• W2034895714 cites W2087771095 @default.
• W2034895714 cites W2093966566 @default.
• W2034895714 cites W2103659092 @default.
• W2034895714 cites W2107873069 @default.
• W2034895714 cites W2150210533 @default.
• W2034895714 cites W2164896821 @default.
• W2034895714 cites W2169073631 @default.
• W2034895714 cites W2229025498 @default.
• W2034895714 cites W2264911488 @default.
• W2034895714 cites W4245376015 @default.
• W2034895714 cites W1705180598 @default.
• W2034895714 cites W2073565082 @default.
• W2034895714 doi "https://doi.org/10.1515/bc.2002.115" @default.
• W2034895714 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12437089" @default.
• W2034895714 hasPublicationYear "2002" @default.
• W2034895714 type Work @default.
• W2034895714 sameAs 2034895714 @default.
• W2034895714 citedByCount "15" @default.
• W2034895714 countsByYear W20348957142012 @default.
• W2034895714 countsByYear W20348957142014 @default.
• W2034895714 countsByYear W20348957142015 @default.
• W2034895714 countsByYear W20348957142017 @default.
• W2034895714 countsByYear W20348957142020 @default.
• W2034895714 countsByYear W20348957142022 @default.
• W2034895714 countsByYear W20348957142023 @default.
• W2034895714 crossrefType "journal-article" @default.
• W2034895714 hasAuthorship W2034895714A5075467879 @default.
• W2034895714 hasAuthorship W2034895714A5082200157 @default.
• W2034895714 hasConcept C104317684 @default.
• W2034895714 hasConcept C181199279 @default.
• W2034895714 hasConcept C182220744 @default.
• W2034895714 hasConcept C185592680 @default.
• W2034895714 hasConcept C2776714187 @default.
• W2034895714 hasConcept C2777132095 @default.
• W2034895714 hasConcept C2777807008 @default.
• W2034895714 hasConcept C2778401398 @default.
• W2034895714 hasConcept C2778965386 @default.
• W2034895714 hasConcept C2779811187 @default.
• W2034895714 hasConcept C2780340462 @default.
• W2034895714 hasConcept C2781307694 @default.
• W2034895714 hasConcept C28021979 @default.
• W2034895714 hasConcept C2909000736 @default.
• W2034895714 hasConcept C55493867 @default.
• W2034895714 hasConcept C86803240 @default.
• W2034895714 hasConceptScore W2034895714C104317684 @default.
• W2034895714 hasConceptScore W2034895714C181199279 @default.
• W2034895714 hasConceptScore W2034895714C182220744 @default.
• W2034895714 hasConceptScore W2034895714C185592680 @default.
• W2034895714 hasConceptScore W2034895714C2776714187 @default.
• W2034895714 hasConceptScore W2034895714C2777132095 @default.
• W2034895714 hasConceptScore W2034895714C2777807008 @default.
• W2034895714 hasConceptScore W2034895714C2778401398 @default.
• W2034895714 hasConceptScore W2034895714C2778965386 @default.
• W2034895714 hasConceptScore W2034895714C2779811187 @default.
• W2034895714 hasConceptScore W2034895714C2780340462 @default.
• W2034895714 hasConceptScore W2034895714C2781307694 @default.
• W2034895714 hasConceptScore W2034895714C28021979 @default.
• W2034895714 hasConceptScore W2034895714C2909000736 @default.
• W2034895714 hasConceptScore W2034895714C55493867 @default.
• W2034895714 hasConceptScore W2034895714C86803240 @default.
• W2034895714 hasIssue "7-8" @default.
• W2034895714 hasLocation W20348957141 @default.

• next